SM

Shivalingappa Malavalli Naveen Kumar

Active Director Director DIN 10627610
DIN 10627610 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivalingappa Malavalli Naveen Kumar

Data last updated:

Shivalingappa Malavalli Naveen Kumar is a Director at Arrigo Health Care Private Limited (since 2024).

DIN 10627610
Primary Designation Director
First Appointment 14 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arrigo Health Care Private Limited U86100KA2024PTC188520
Director14 May 20242024Active

Board colleagues of Shivalingappa Malavalli Naveen Kumar

Directorship timeline

Open interactive timeline →
Arrigo Health Care Private Limited
Premium access

Shareholding and investment profile for Shivalingappa Malavalli Naveen Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivalingappa Malavalli Naveen Kumar

Shivalingappa Malavalli Naveen Kumar currently holds 1 directorship: Arrigo Health Care Private Limited (Director, since 14 May 2024).

Shivalingappa Malavalli Naveen Kumar was first appointed on 14 May 2024 as Director at Arrigo Health Care Private Limited.

The current boards of Shivalingappa Malavalli Naveen Kumar's companies include Channapatna Shanthakumar Bhagavan (Arrigo Health Care Private Limited), Puttachar Basavalingachary (Arrigo Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available